Dyslexia Treatment Global Market Report 2024

Treatment for dyslexia encompasses a variety of approaches and interventions aimed at enhancing the reading, writing, and spelling abilities of individuals with dyslexia. These typically involve specialized educational programs, including structured literacy and multisensory instruction, which utilize visual, auditory, and kinesthetic methods to support learning. Consistent practice, personalized assistance, and early intervention are crucial elements of effective dyslexia treatment.

There are several types of dyslexia treatment, such as double-deficit dyslexia, visual dyslexia, and phonological dyslexia. Double-deficit dyslexia involves challenges in both phonological processing (the ability to recognize the sound structure of words) and naming speed (the ability to quickly name letters and numbers). Therapy options for dyslexia include occupational therapy, speech therapy, and cognitive behavioral therapy, alongside medications such as cyclizine, meclizine, dimenhydrinate, methylphenidate, among others. These treatments are accessed through hospital pharmacies, retail pharmacies, and other distribution channels, catering to various end users such as psychiatric institutions, rehabilitation centers, and home care services.

The dyslexia treatment market research report is one of a series of new reports that provides dyslexia treatment market statistics, including dyslexia treatment industry global market size, regional shares, competitors with a dyslexia treatment market share, detailed dyslexia treatment market segments, market trends and opportunities, and any further data you may need to thrive in the dyslexia treatment industry. This dyslexia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dyslexia treatment market size has grown strongly in recent years. It will grow from $26.36 billion in 2023 to $28.14 billion in 2024 at a compound annual growth rate (CAGR) of 6.9%. The growth observed in the historical period can be attributed to global cooperation and the exchange of best practices, evolving societal perspectives on learning disabilities, adoption of holistic treatment strategies integrating psychological, educational, and medical interventions, increased financial support from both governmental and private sectors for research and educational initiatives, and the enactment of laws mandating support for students with learning disabilities.

The dyslexia treatment market size is expected to see strong growth in the next few years. It will grow to $37.06 billion in 2028 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to heightened parental awareness about dyslexia, implementation of inclusive education policies and specialized educational programs tailored for dyslexic students, a rising number of diagnosed dyslexia cases, ongoing professional development initiatives for educators and therapists, and the expanding availability of telehealth and online therapy services. Key trends anticipated in the forecast period include the integration of artificial intelligence tools for early detection and personalized treatment plans, adoption of software-driven interventions, utilization of real-time brain activity monitoring to enhance reading skills, advanced speech-to-text applications to assist dyslexic individuals in reading and writing tasks, and increasing demand for cognitive monitoring devices that provide feedback to support learning and concentration efforts.

The increasing prevalence of neurological disorders is expected to drive growth in the dyslexia treatment market in the coming years. Neurological disorders encompass a range of medical conditions affecting the nervous system, including the brain, spinal cord, and nerves. Factors contributing to the rising prevalence of these disorders include an aging population, changes in lifestyle, environmental factors, and improved diagnostic capabilities leading to better detection and reporting. Treatments for dyslexia, such as multisensory learning and cognitive training, hold promise for improving neurological conditions by enhancing brain plasticity and cognitive functions. According to the World Health Organization (WHO) in March 2024, more than 3 billion people globally were living with a neurological condition, with over 80% of related deaths and health losses occurring in low- and middle-income countries. Disparities in access to treatment are significant, with high-income countries having substantially more neurological professionals per capita compared to low- and middle-income countries. Therefore, the increasing prevalence of neurological disorders is a driving force behind the growth of the dyslexia treatment market.

Leading companies in the dyslexia treatment market are focusing on developing advanced solutions, including customized programs, to better meet the needs of their clientele. Customized programs involve tailored educational plans and interventions designed specifically to address the unique learning requirements of students with dyslexia. For example, in May 2021, Microsoft Corporation collaborated with Made by Dyslexia, a UK-based organization, to launch a free online training program aimed at helping educators identify and support students with dyslexia. This initiative aims to empower teachers with the knowledge to understand the strengths and challenges of dyslexic learners and to develop effective teaching strategies and technology tools for creating inclusive classrooms. The training modules cover various aspects of dyslexia awareness and support.

In December 2022, Kyndryl Canada partnered with Dyslexia Canada to promote equitable access to education for students with dyslexia. This collaboration aims to raise awareness about the educational challenges faced by children and youth with dyslexia and to advocate for solutions that ensure fair and accessible education opportunities. Dyslexia Canada, a national charity based in Canada, is dedicated to improving the lives of children with dyslexia across the country.

Major companies operating in the dyslexia treatment market are Pfizer Inc., Astrazeneca Plc, Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Purdue Pharma, Apotex Corporation, Endo International Plc, Amneal Pharmaceuticals LLC, Unither Pharmaceuticals LLC, RPG Life Sciences Ltd., Jubilant Pharma Limited, Breckenridge Pharmaceutical Inc., Rhodes Pharmaceuticals L.P., Cian Healthcare Pvt. Ltd, Lexia Learning Systems LLC, Wallace Pharmaceuticals Ltd., Ironshore Pharmaceuticals Inc., DK Pharmachem Pvt Ltd., Speechify Inc., Lingit AS, Lyfta, Nessy Learning Ltd.

North America was the largest region in the dyslexia treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dyslexia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the dyslexia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The dyslexia treatment market consists of revenues earned by entities by services such as literacy programs, multisensory interventions, assistive technologies, individualized education plans, cognitive training, and therapies targeting visual and auditory processing skills. The market value includes the value of related goods sold by the service provider or included within the service offering. The dyslexia treatment market also includes sales of assistive listening devices, phonological processing tools, digital pens and notetaking devices, eye-tracking devices, and multi-sensory learning tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.